Characterization of intra-graft B cells during renal allograft rejection

Kidney International

Volumn 74, Issue 5, 2008, Pages 664-673

  Zarkhin, Valeriya ^a   Kambham, Neeraja ^b   Li, Li ^a   Kwok, Shirley ^b   Hsieh, Szu Chuan ^a   Salvatierra, Oscar ^a   Sarwal, Minnie M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B lymphocytes; Graft survival; Intra graft CD20+ and CD38+ infiltrates; Renal allograft rejection; Transplant biopsy

Indexed keywords

CD20 ANTIGEN; CD79A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STEROID;

ANTIBODY DETECTION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL LINEAGE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY PARENCHYMA; MEMORY CELL; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; TISSUE MICROARRAY;

ADULT; ANTIGENS, CD20; ANTIGENS, CD38; B-LYMPHOCYTE SUBSETS; CHEMOKINES; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOPHENOTYPING; KIDNEY TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMA CELLS;

EID: 49749118283     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.249     Document Type: Article

References (43)

1. Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138.
2. + infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5: 2248-2252.
3. +) in renal allograft biopsy specimens. Transplant Proc 2007; 39: 432-434.
4. Krukemeyer MG, Moeller J, Morawietz L et al. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004; 78: 65-70.
5. + lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation 2006; 82: 1769-1773.
6. Alausa M, Almagro U, Siddiqi N et al. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Clin Transplant 2005; 19: 137-140.
7. Bagnasco SM, Tsai W, Rahman MH et al. CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. Am J Transplant 2007; 7: 1968-1973.
8. Kayler LK, Lakkis FG, Morgan C et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant 2007; 7: 949-954.
9. Doria C, di Francesco F, Ramirez CB et al. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft. Transplant Proc 2006; 38: 3441-3444.
10. Noorchashm H, Reed AJ, Rostami SY et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 2006; 177: 7715-7722.
11. Steinmetz OM, Panzer U, Kneissler U et al. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005; 67: 1616-1621.
12. Eisen MB, Spellman PT, Brown PO et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
13. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817.
14. Grogg KL, Attygalle AD, Macon WR et al. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006; 19: 1101-1107.
15. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
16. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
17. Angeli V, Ginhoux F, Llodra J et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006; 24: 203-215.
18. Martin F, Chan AC. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 2004; 20: 517-527.
19. Martin F, Chan AC. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006; 24: 467-496.
20. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612.
21. Stuht S, Gwinner W, Franz I et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am J Transplant 2007; 7: 377-384.
22. Tarlinton D. B-cell memory: are subsets necessary? Nat Rev Immunol 2006; 6: 785-790.
23. Cassese G, Lindenau S, de Boer B et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001; 31: 2726-2732.
24. Magalhaes R, Stiehl P, Morawietz L et al. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 2002; 441: 415-427.
25. Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 1996; 10: 1408-1417.
26. Kambham N, Kong C, Longacre TA et al. Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases. Appl Immunohistochem Mol Morphol 2005; 13: 304-310.
27. Campana D, Suzuki T, Todisco E et al. CD38 in hematopoiesis. Chem Immunol 2000; 75: 169-188.
28. Pers JO, Devauchelle V, Daridon C et al. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjogren's syndrome. Arthritis Rheum 2007; 56: 1464-1477.
29. Avery DT, Ellyard JI, Mackay F et al. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J Immunol 2005; 174: 4034-4042.
30. Lerut E, Kuypers DR, Verbeken E et al. Acute rejection in non-compliant renal allograft recipients: a distinct morphology. Clin Transplant 2007; 21: 344-351.
31. Nickeleit V, Zeiler M, Gudat F et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242-251.
32. Seemayer CA, Gaspert A, Nickeleit V et al. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568-576.
33. Kerjaschki D. Lymphatic neoangiogenesis in renal transplants: a driving force of chronic rejection? J Nephrol 2006; 19: 403-406.
34. Ellyard JI, Avery DT, Mackay CR et al. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54. Eur J Immunol 2005; 35: 699-708.
35. Hollenbaugh D, Mischel-Petty N, Edwards CP et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33-40.
36. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
37. Lehnhardt A, Mengel M, Pape L et al. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab. Am J Transplant 2006; 6: 847-851.
38. Faguer S, Kamar N, Guilbeaud-Frugier C et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 2007; 83: 1277-1280.
39. Becker YT, Becker BN, Pirsch JD et al. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 2004; 4: 996-1001.
40. Genberg H, Hansson A, Wernerson A et al. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 2006; 6: 2418-2428.
41. Jordan SC, Quartel AW, Czer LS et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998; 66: 800-805.
42. Schwartz GJ, Haycock GB, Edelmann Jr CM et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
43. Liu CL, Prapong W, Natkunam Y et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002; 161: 1557-1565.